PCN121 ONCOLOGY MEDICATION UTILIZATION BASED ON FEDERAL DRUG ADMINISTRATION (FDA) LABELING, NATIONAL COMPREHENSIVE CANCER NETWORK (NCCN) CLINICAL PRACTICE GUIDELINE (GL) RECOMMENDATIONS, AND EVIDENCE FOR PATIENTS WITH ADVANCED NON SMALL CEL ...
Abstract
Authors
E.M. Lepisto J.L. Vandergrift G.P. Kalemkerian K.M. Pisters C. Zornosa M.S. Rabin M.E. Reid M. Koczywas G.A. Otterson D.S. Ettinger